Lilly’s Retatrutide Raises Weight-Loss Bar In First Phase III Readout

 
• By Joseph Haas
  
This is a picture of the Lilly building in San Diego
Lilly's retatrutide reported its first Phase III data, showing weight loss, knee pain improvement (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business